Overview and Scope
Epigenetics is a change in gene activity transmitted to younger cells without modifying the DNA sequence. Epigenetic processes are natural and necessary for many organisms to work, but unusual occurrences can cause disorders, such as various types of cancer, reproductive illnesses, and cardiovascular illnesses. Epigenetics is used detect a type of cancers earlier.
Sizing and Forecast
The epigenetics market size has grown exponentially in recent years. It will grow from <b>$9 billion in 2023 to $10.91 billion in 2024 at a compound annual growth rate (CAGR) of 21.2%. </b> The growth in the historic period can be attributed to increased research funding, rise in incidence of chronic diseases, personalized medicine, cancer research, aging population.
The epigenetics market size is expected to see exponential growth in the next few years. It will grow to <b>$23.86 billion in 2028 at a compound annual growth rate (CAGR) of 21.6%. </b> The growth in the forecast period can be attributed to epigenetic drug development, epigenetics in environmental health, epigenetics in precision agriculture, regulatory support, patient awareness and advocacy. Major trends in the forecast period include epitranscriptomics, single-cell epigenomics, epigenetic editing, epigenetic biomarkers, aging and longevity research, microbiome-epigenome interactions.
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/epigenetics-global-market-report
Segmentation & Regional Insights
The epigenetics market covered in this report is segmented –
1) By Product: Reagents, Enzymes, Instruments, Kits
2) By Technology: DNA Methylation, Histone Methylation, Histone Acetylation, Large Noncoding RNA, MicroRNA Modification, Chromatin Structures
3) By Application: Oncology, Metabolic Diseases, Developmental Biology, Immunology, Cardiovascular Diseases, Other Applications
4) By End-User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Contract Research Organisations, Other End Users
<b>North America</b> was the largest region in the epigenetics market in 2023. <b>Asia-Pacific</b> is expected to be the fastest-growing region in the epigenetics market during the forecast period. The regions covered in the epigenetics market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7070&type=smp
Major Driver Impacting Market Growth
The growing prevalence of cancer and other diseases is significantly driving the growth of the epigenetics market. The rising prevalence of diseases increases the demand for epigenetics. For instance, in September 2021, According to the European Commission’s Joint Research Centre from Ispra, the number of new cancer cases in the European Union (EU) and European Free Trade Association (EFTA) countries will rise by 21.4%, from 2.8 million in 2020 to 3.4 million in 2040. Furthermore, according to the Centers for Disease Control and Prevention (CDC), approximately 659,000 people in the United States die of heart disease each year. The increasing prevalence of cancer and other diseases requires testing and knowing the modifications that happened in the genes, which will invariably increase the usage and demand of epigenetics. Thus, the growing prevalence of cancer and other diseases drives the epigenetics market in the coming years.
Key Industry Players
Major companies operating in the epigenetics market include <b> Illumina Inc., Thermo Fisher Scientific, Merck Millipore, Abcam, Active Motif, Abcam PLC, Active Motiff, Hologic Inc., Qiagen NV, Diagenode SA, CellCentric Ltd., Chroma Medicine Inc., Constellation Pharmaceuticals Inc., Cytosine Therapeutics, Domainex Ltd., Eisai Co. Ltd., Epigen Biosciences Inc., EpigenDx Inc., Epigenomics AG, Epizyme Inc., Gilead Sciences Inc., GlaxoSmithKline plc, Janssen Pharmaceuticals Inc., Locus Biosciences Inc., MDxHealth SA, Novartis AG, OncoDNA SA, Oryzon Genomics S.A., Pfizer Inc., Syndax Pharmaceuticals Inc., Valirx plc, Zymeworks Inc. </b>
The epigenetics market report table of contents includes:
1. Executive Summary
2. Epigenetics Market Characteristics
3. Epigenetics Market Trends And Strategies
4.Epigenetics Market analysis
5. Epigenetics Market Size And Growth
6. Epigenetics Segmentation
7.Epigenetics Regional And Country Analysis
.
.
.
27.Epigenetics Competitive Landscape And Company Profiles
28.Epigenetics Key Mergers And Acquisitions
29. Epigenetics Future Outlook and Potential Analysis
TOP MAJOR PLAYERS:
- Illumina Inc.
- Thermo Fisher Scientific
- Merck Millipore,
- Abcam
- Active Motif
Explore the trending research reports from TBRC:
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
